These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 26572892

  • 1. aHUS associated with C3 gene mutation: a case with numerous relapses and favorable 20-year outcome.
    Siomou E, Gkoutsias A, Serbis A, Kollios K, Chaliasos N, Frémeaux-Bacchi V.
    Pediatr Nephrol; 2016 Mar; 31(3):513-7. PubMed ID: 26572892
    [Abstract] [Full Text] [Related]

  • 2. [Atypical hemolytic-uremic syndrome related to abnormalities within the complement system].
    Frémeaux-Bacchi V, Fakhouri F, Roumenina L, Dragon-Durey MA, Loirat C.
    Rev Med Interne; 2011 Apr; 32(4):232-40. PubMed ID: 21376430
    [Abstract] [Full Text] [Related]

  • 3. Disease Recurrence After Early Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome With Complement C3 I1157T Mutation.
    Toyoda H, Wada H, Miyata T, Amano K, Kihira K, Iwamoto S, Hirayama M, Komada Y.
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):e137-9. PubMed ID: 26840081
    [Abstract] [Full Text] [Related]

  • 4. Analysis of patients with atypical hemolytic uremic syndrome treated at the Mie University Hospital: concentration of C3 p.I1157T mutation.
    Matsumoto T, Fan X, Ishikawa E, Ito M, Amano K, Toyoda H, Komada Y, Ohishi K, Katayama N, Yoshida Y, Matsumoto M, Fujimura Y, Ikejiri M, Wada H, Miyata T.
    Int J Hematol; 2014 Nov; 100(5):437-42. PubMed ID: 25135378
    [Abstract] [Full Text] [Related]

  • 5. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.
    Semin Thromb Hemost; 2014 Jun; 40(4):422-30. PubMed ID: 24799305
    [Abstract] [Full Text] [Related]

  • 6. A large family with a gain-of-function mutation of complement C3 predisposing to atypical hemolytic uremic syndrome, microhematuria, hypertension and chronic renal failure.
    Lhotta K, Janecke AR, Scheiring J, Petzlberger B, Giner T, Fally V, Würzner R, Zimmerhackl LB, Mayer G, Fremeaux-Bacchi V.
    Clin J Am Soc Nephrol; 2009 Aug; 4(8):1356-62. PubMed ID: 19590060
    [Abstract] [Full Text] [Related]

  • 7. A Novel Homozygous In-Frame Deletion in Complement Factor 3 Underlies Early-Onset Autosomal Recessive Atypical Hemolytic Uremic Syndrome - Case Report.
    Pollack S, Eisenstein I, Mory A, Paperna T, Ofir A, Baris-Feldman H, Weiss K, Veszeli N, Csuka D, Shemer R, Glaser F, Prohászka Z, Magen D.
    Front Immunol; 2021 Aug; 12():608604. PubMed ID: 34248927
    [Abstract] [Full Text] [Related]

  • 8. Atypical hemolytic uremic syndrome with C3 mutation: A case report and literature review.
    Liu J, Xiao J, Chen L, Peng Y.
    Clin Nephrol; 2021 Mar; 95(3):156-160. PubMed ID: 33210998
    [Abstract] [Full Text] [Related]

  • 9. The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndrome.
    Martínez-Barricarte R, Heurich M, López-Perrote A, Tortajada A, Pinto S, López-Trascasa M, Sánchez-Corral P, Morgan BP, Llorca O, Harris CL, Rodríguez de Córdoba S.
    Mol Immunol; 2015 Aug; 66(2):263-73. PubMed ID: 25879158
    [Abstract] [Full Text] [Related]

  • 10. [Atypical hemolytic uremic syndrome with C3 p.I1157T missense mutation successfully treated with eculizumab].
    Okano M, Matsumoto T, Nakamori Y, Ino K, Miyazaki K, Fujieda A, Sugimoto Y, Tawara I, Yamaguchi M, Ohishi K, Miwa H, Masuya M, Wada H, Katayama N.
    Rinsho Ketsueki; 2018 Aug; 59(2):178-181. PubMed ID: 29515070
    [Abstract] [Full Text] [Related]

  • 11. The Relevance of the MCP Risk Polymorphism to the Outcome of aHUS Associated With C3 Mutations. A Case Report.
    Lumbreras J, Subias M, Espinosa N, Ferrer JM, Arjona E, Rodríguez de Córdoba S.
    Front Immunol; 2020 Aug; 11():1348. PubMed ID: 32765494
    [Abstract] [Full Text] [Related]

  • 12. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.
    Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
    [Abstract] [Full Text] [Related]

  • 13. Renal Damage in Recurrent Atypical Hemolytic Uremic Syndrome Associated with C3 p.Ile1157Thr Gene Mutation.
    Okabe M, Kobayashi A, Marumoto H, Koike K, Yamamoto I, Kawamura T, Tsuboi N, Yokoo T.
    Intern Med; 2021 Mar 15; 60(6):917-922. PubMed ID: 33087669
    [Abstract] [Full Text] [Related]

  • 14. Life-Threatening Extrarenal Manifestations in an Infant with Atypical Hemolytic Uremic Syndrome Caused by a Complement 3-Gene Mutation.
    Han SR, Cho MH, Moon JS, Ha IS, Cheong HI, Kang HG.
    Kidney Blood Press Res; 2019 Mar 15; 44(5):1300-1305. PubMed ID: 31522186
    [Abstract] [Full Text] [Related]

  • 15. Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.
    Frémeaux-Bacchi V, Miller EC, Liszewski MK, Strain L, Blouin J, Brown AL, Moghal N, Kaplan BS, Weiss RA, Lhotta K, Kapur G, Mattoo T, Nivet H, Wong W, Gie S, Hurault de Ligny B, Fischbach M, Gupta R, Hauhart R, Meunier V, Loirat C, Dragon-Durey MA, Fridman WH, Janssen BJ, Goodship TH, Atkinson JP.
    Blood; 2008 Dec 15; 112(13):4948-52. PubMed ID: 18796626
    [Abstract] [Full Text] [Related]

  • 16. Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report.
    Bahougne T, Olagne J, Munch M, Braun-Parvez L, Chenard MP, Frémeaux-Bacchi V, Caillard S, Baltzinger P, Greget M, Kessler L, Moulin B.
    BMC Nephrol; 2020 Sep 19; 21(1):405. PubMed ID: 32950058
    [Abstract] [Full Text] [Related]

  • 17. Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.
    Volokhina E, Westra D, Xue X, Gros P, van de Kar N, van den Heuvel L.
    Pediatr Nephrol; 2012 Sep 19; 27(9):1519-24. PubMed ID: 22669319
    [Abstract] [Full Text] [Related]

  • 18. Case Report: Combined Liver-Kidney Transplantation to Correct a Mutation in Complement Factor B in an Atypical Hemolytic Uremic Syndrome Patient.
    López-Trascasa M, Alonso-Melgar Á, Melgosa-Hijosa M, Espinosa-Román L, Lledín-Barbancho MD, García-Fernández E, Rodríguez de Córdoba S, Sánchez-Corral P.
    Front Immunol; 2021 Sep 19; 12():751093. PubMed ID: 34721423
    [Abstract] [Full Text] [Related]

  • 19. Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report.
    Osawa K, Yamamoto S, Yamano Y, Kita A, Okamoto K, Kato N, Tatematsu Y, Kojima F, Ohya M, Hara S, Murata SI, Inoue N, Maruyama S, Araki SI.
    Intern Med; 2024 Jun 15; 63(12):1777-1782. PubMed ID: 37926536
    [Abstract] [Full Text] [Related]

  • 20. Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome.
    Mele C, Lemaire M, Iatropoulos P, Piras R, Bresin E, Bettoni S, Bick D, Helbling D, Veith R, Valoti E, Donadelli R, Murer L, Neunhäuserer M, Breno M, Frémeaux-Bacchi V, Lifton R, Remuzzi G, Noris M.
    Clin J Am Soc Nephrol; 2015 Jun 05; 10(6):1011-9. PubMed ID: 25854283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.